CANbridge
formerly CANbridge PharmaceuticalsIPOBringing transformative therapies to rare disease patients in China and beyond
Burlington, China · Founded 2012 · $211.0M raised
- Headquarters
- Burlington
- Employees
- 201–500
- Founded
- 2012
- Business Model
- B2B
- Website
- canbridgepharma.com
- Total Funding
- $211.0M
- Last Round
- $43.0M Series EDec 2020
- Rounds
- 6
About
CANbridge Pharmaceuticals (HKEX: 1228) is a global biopharmaceutical company with a foundation in China, committed to the research, development, and commercialization of rare disease therapeutics. The company has a differentiated drug portfolio with 3 approved drugs and a pipeline of 7 clinical assets, focusing on prevalent rare disease indications including mucopolysaccharidosis, Gaucher disease, and other rare genetic disorders. CANbridge operates a Next-Generation Innovation and Process Development Facility developing novel gene therapies, and partners globally with leading biotech and pharma companies to bring treatments to patients in China and worldwide.
Summary
CANbridge is a Life Sciences company based in Burlington, China, founded in 2012. It has raised $211.0M in total across 6 rounds, most recently a $43.0M Series E round in Dec 2020. Investors include Qiming VP, Hong Kong Stock Exchange and Lapam Capital.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Dec 2021
Sign up to see all 7 rounds
Series A through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/canbridge"><img src="https://indexed.vc/api/badge/company/canbridge" alt="CANbridge on Indexed.vc" width="260" height="76" /></a>